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ABSTRACT 
Objective: The purpose of this study was to investigate Na-montmorillonite (Na-MMT) intercalated medium molecular weight (MMW) chitosan as 
an oral drug delivery vehicle for In Vitro release of theophylline sustained release tablet.  
Methods: Montmorillonite (MMT) clay were synthesized into Na-MMT and treated with chitosan. Combination becomes synthesis of Na-
montmorillonite intercalated MMW chitosan
Results: XRD spectra results showed 15.43 Å MMT basal spacing. Na-MMT was synthesized and distance between the layers value was 15.225 Å, 
this was because the smaller size of impurity cations than Na
. Parameters tested including MMT characterization as well as already intercalated using XRD, FTIR and 
SEM. Tablets were prepared using the wet granulation method. The physical properties evaluation was conducted on granules and tablets. 
Dissolution test used apparatus II USP model with 100 rpm of speed rotation for 6 hours and phosphate buffer pH 7.2 as a medium. Absorbance of 
the sample was measured on a spectrophotometer. 
+ cation. After intercalation with chitosan, distance between layers became wider to 
15.94Å. Characterization results with FTIR spectra on MMT intercalated MMW chitosan exposed similarities with Na-MMT, small shift was 
occurred. This indicated that intercalation with chitosan did not change the structure of Alumina silicate MMT. However, the physical properties of 
the granule were not affected by any difference of components formula. Tablets physical properties still meet the reference requirements. Tablets 
with dissolution efficiency has different values with different composition formulas
Conclusion: Characteristics of the MMT, Na-MMT, Na-MMT intercalated MMW chitosan did not change much. The intercalation process of Na-MMT 
with chitosan further accelerates drug release compared to MMT and exhibited a prolonged release as compared to the pure drug without MMT. 
. 
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INTRODUCTION 
Clay minerals have been proposed as fundamental constituents of 
several modification of drug delivery systems, with different 
purposes and acting through various mechanisms. Based on their 
high retention capacities as well as swelling and colloidal properties, 
clays have been proposed as useful materials to modify drug 
delivery. Because of their swelling potential, clay minerals can be 
effectively used to delay (extended-release systems) drug release or 
even improve drug solubility [1].  
MMT is a natural mineral consists of an insoluble large layer and 
weakly bound cations to the space between layers. Each layered 
hydrated aluminum silicate whose unit cell is composed of one Al-
octahedral sheet (O) sandwiched between two Si–tetrahedral sheets 
(T). It possesses a net negative charge due to isomorphous ionic 
substitutions in the T–O–T structure. This charge is compensated by 
interlayer hydrated cations, which can be exchanged by a variety of 
organic molecules [1,2]. MMT is able to swell with the addition of large 
cations into the space between the layer of MMT [3,4,5]. Intercalated 
clay is a derivative of smektit which the cations have been exchanged 
by large cations and these cations serves as a pillar of support between 
MMT layer [6]. MMT is a smectite group clay and has a large specific 
surface area, good adsorption,and cation exchange capacity [7]. 
Intercalation is a process of atoms or molecules insertion into the 
interlayer of layered material without damaging the layer structure 
[6]. Intercalation into interlayer of silicate clay occured because of 
incoming intercalate (atoms or molecules that will be inserted) as 
cation or positively charged ions replaced cations in interlayer of 
clay for example Na+, K+, Ca2+
Intercalation with inorganic polyhydroxy cations followed by heat 
treatment will form intercalated clays by metal oxides which 
typically have a high thermal stability [8,9]. Intercalation is insertion 
of a pillar agent into clay silicate interlayer so intercalated clay 
compound is obtained. Intercalation will increase the chemical and 
physical properties that include basal spacing (d
. These cations are generally not bound 
so it easily moved or exchanged with intercalate cations. This 
process was often called cation exchange. 
001
MMT is the most commonly used natural clays and has been 
successfully applied in numerous nanocomposite systems [11,12]. 
Some of MMT uses have been made to the controlled drug release 
[13-23]. Dispersion of chitosan on the MMT surface opens the 
functional groups that could potentially form a hydrogen bond with 
theophylline. Chitosan being a cationic, hydrophilic, nontoxic, 
biocompatible, and bioabsorbable polymer is a popular material for 
drug delivery applications [24]. Chitosan has also been used to 
prepare nanocomposites with MMT for prolonged release and 
biomedical applications [25,26]. In particular, chitosan chains have 
been described to intercalate with Na-MMT, because of their 
hydrophilic and cationic character, giving hybrid nanocomposite 
materials with interesting properties [27]. Other works showed that 
the ratio between MMT and chitosan was a crucial factor also in the 
case of nanocomposites prepared to control the release of the 
chemotherapeutic agent doxorubicin [28]. 
), specific 
surface, porosity and acidity of MMT [10]. 
In this research work, an attempted has been done to design and 
evaluate drug release of theophylline sustained release tablet 
formulation using Na-MMT intercalated MMW chitosan. Theophylline 
was chosen as a model drug due to its efficiency to treat chronic 
obstructive pulmonary disease, and a narrow therapeutic index which 
requires regular monitoring of serum theophylline concentrations. In 
this way slow release forms of theophylline can be used to avoid 
adverse effects and promote its efficient use. 
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MATERIALS AND METHODS 
Materials 
Theophylline (Shandong Pharm, China), lactose, starch, methocel 
K15M (Hydroxypropylmetylcellulose HPMC type 2208 with 15,000 
cps viscosity), buffer phosphate pH 7.2 liquid, natural 
montmorillonite obtained from Wonosegoro Boyolali Indonesia, 
Medium molecular weight (MMW) chitosan (200,000 cps viscosity) 
obtained from Aldrich Singapore, magnesium stearate, talc, 
aquadest, NaCl (E. Merck, Germany), AgNO3 (E. Merck, Germany), 
NaOH (E. Merck, Germany), Acetic Acid (E. Merck, Germany). 
Preparation and characterization of Initial Montmorillonite 
MMT had been purified from bentonite which were obtained from 
Wonosegoro, Boyolali, Central Java, Indonesia. Rough bentonite 
were taken and washed with demineralized water, the colloid phase 
was precipitated one night. The sediment was dried at 1100C in the 
oven (Memmert) for a day. This process was repeated for 5 times. 
Dried MMT then sifted with 180 mesh sieve, identified and 
characterized with X-Ray Difractometer (XRD) Shimadzu type 6000. 
Synthesis of Na-Montmorillonite 
MMT of 70 grams was added into 1.5 L Natrium Chloride 1M liquid. 
The suspension was stirred with magnetic stirrer for 24 hours in the 
temperature range of 55-600C. Sediment was separated from the 
suspension by decantation. Obtained sediment was washed with 
aquadest to remove the remaining chloride ion. To make sure that 
there is no longer chloride ion remaining on the clay surface, the 
water that used to wash the sediment was tested with AgNO3 1M 
liquid. If this test shows a negative result of AgNO3, it means that it 
did not form white sediment of AgCl. Formed Na-MMT were dried at 
1000
Synthesis of Na-montmorillonite intercalated MMW chitosan 
C in the oven. 
Composite manufacture with chitosan: clay ratio of 0.603:1.500; 
1.206:1.500; 2.415:1.500; and 4.830:1.500 conducted with making a 
chitosan suspension of 4.83 grams into 750 ml 1% acetic acid, then 
stirred for 4 hours at room temperature. NaOH 4M was added into 
suspension until pH 4.9 reached using a pH meter (Hanna 8514). 
Next, 750 ml of clay suspension 2% (1.5 gram Na-MMT on 750 ml 
aquadest) added carefully at temperature of 500C. This mixture then 
stirred for 2 days, then washed with aquadest until free from 
acetate. This material then called Na-MMT clay intercalated 
chitosan. For characterization, composite were dried at 500




Characterization with X-Ray Diffraction (XRD) Shimadzu Type 6000 
tested the crystallinity of clay. XRD reflection intensity indicates 
about the perfection of the crystal and the density of the atoms 
arrangement in a crystal. An intensity reflection peaks that were 
increasingly sharp indicates better clay crystallinity with close 
atoms arrangement. XRD data were compared to initial 
diffractogram basal spacing and intercalated to find out the 
optimum MMT intercalation. Functional group which contained in 
clay from Wonosegoro was analyzed using Fourier Transform 
Infrared (FT-IR) Spectrophotometer Shimadzu type 8201 PC. MMT 
Clay has an absorbance at certain area. To prove that chitosan had 
been entered into MMT basal spacing, analysis was done using a 
Philips XL30 CP scanning electronic microscopy (SEM) to study 
surface morphology from composite after intercalation process 
conducted with chitosan. With this analysis, differences will be seen 
between montmorillonite before involving intercalation and 
montmorillonite after intercalation with chitosan. 
 
Table 1: Matrix Composition Formula 
Composition Content per tablet (mg) 
F I F II F III FIV 
Theophylline 200 200 200 200 
Montmorillonite (MMT) - - 85 - 
Na-montmorillonit(Na-MMT) Intercalated MMW chitosan  - - - 85 
HPMC - 85 - - 
Lactose 137.5 95 95 95 
Starch  137.5 95 95 95 
Magnesium stearate 1 1 1 1 
Talc 9 9 9 9 
Starch mucilage 15 10% 15 15 15 
 
Formula Composition 
Preparation of Theophylline Tablet 
Theophylline granules were prepared using wet granulation. 
Theophylline, matrix material (for Na-MMT intercalated MMW 
chitosan ratio 1.500:2.415), starch, and also lactose were mixed until 
homogeneous with cube mixer for 10 minutes at agitation speed of 
90 rpm. Few binding agents starch mucilage10% were added into 
the mixture so wet mass granule was formed. Wet Mass granules 
were passed through 16 mesh sieve, then dried at 600
In Vitro drug release 
C for 3 hours. 
Dried granules were passed through 18 mesh sieve, then mixed with 
magnesium stearate and talc in a tumbler for 10 minutes at agitation 
speed of 90 rpm. Physical properties of granule test were conducted 
to find out the feasibility of physical properties before compressed 
into tablets, includes: test of flow time, angle of repose and carr’s 
index using volumenometer (Makita). Physical properties of granule 
that has been examined, then compressed into tablets using single 
punch tablet machine (korsch, Germany) with 500 mg weight per 
tablet. Compression pressure in the manufacture of the tablets was 
maintained at 60-70 N so that the weight of the tablet in every 
formula is all the same. Physical properties of tablets conducted 
including: weight variation test, hardness test using hardness tester 
(Gouming YD-1), and friability test using friability tester (Roche). 
Dissolution test of theophylline sustained release preparation using 
dissolution paddle type apparatus (Electrolab TD-08) USP XXIII 
model with paddle stirrer was done in the following way: medium 
phosphate buffer pH 7.2 500 ml was added to dissolution flask, 
paddle stirrer maintained at an agitation speed of 100 rpm with 2.5 
cm distance of paddle stirrer from the bottom. Tablets then weighed 
and added into dissolution flask. The experimental temperature was 
maintained at a rate of 37 ± 0.5 °C. A sample was taken 5 ml at every 
15, 30, 45, 60, 90, 120, 240, 300, 360 minutes. These samples were 
exchanged with new dissolution medium with the same amount so 
the volume of dissolution medium was fixed. Absorbance of the 
samples was measured using a spectrophotometer UV (Genesys 10, 
Thermo) at a theophylline maximum wavelength (λmax 
RESULTS AND DISCUSSION 
= 272 nm) 
based on maximum wavelength that has been tested. Furthermore, 
theophylline levels were determined using the standard curve that 
has been made. 
Preparation of montmorillonite 
The montmorillonite (MMT) that have been used in this study was 
natural MMT which was purged from impurity by taking the colloid 
Ainurofiq et al. 
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phase. MMT was analyzed by XRD to find out the character of MMT 
as shown in figure 1. 
 














Fig. 1: Diffractogram of natural MMT 
 
Figure 1 shows MMT diffractogram results with 3 strongest peaks at 
2θ that were 5.720o; 6.000o; 26.674owith d value of 15.438 Å; 14.718 
Å and 3.339 Å. The strongest peak with highest intensity peak was 
used as an identifier of mineral. Diffractogram data in figure 1 shows 
diffraction peaks with the highest intensity at 2θ was 5.720o. Joint 
Committee on Powder Diffraction Standards (JCPDS) data main 
diffraction peak MMT intensity at 2θ was 5o-6owith a diameter of 
12.3Å-17.7Å. So, this diffractogram data showed that the main 
mineral constituent in clays was MMT. 
Preparation of Na-Montmorillonite 
MMT were modified into Na-MMT prior to intercalation. Na+ cation 
was used to extrude metal impurities in MMT. Other than that, Na+ 
also used as exchanged agent and replaced by Ammonium ion in 
chitosan. Diffractogram of Na-MMT as shown in figure 2, there was a 
slight shift of the 2θ peak to the right. It showed that decreasing 
basal spacing (d001) was occurred. It was caused by the smaller Na+


















cation size than dopants cation size. Distance between layers of Na-
MMT in figure 3 became 15.20 Å which was decreasing in size. The 
effect from this decrease was Na-MMT in water became smaller size 
colloid phase It was harder to precipitate than MMT. 
 
 
Fig. 2: Diffractogram of Na-MMT 
 
Decreasing of basal spacing (d001) from MMT showed that MMT 
modification into Na-MMT had been successfully done. The effects of 
this modification increased the swelling ability from MMT when 
being dispersed in aquadest, so the MMT pores would open wider 
and chitosan would be easier to enter between MMT layers. 




Fig. 3: Distance between layers: a). initial MMT b). Na-MMT 
 
Characterization of MMW chitosan 
The FTIR spectrum absorbance of a polycation has a typical pattern 
that allows to identify polycation and also to unveil the presence of 
main functional groups within the structure of identified compound. 
The Analysis result by spectrophotometer FTIR was given in figure 
4. The result showed that chitosan have a ring group stretching (C-H 
cyclo or ring), C-O asym & C-Osym stretching, bridge-O-stretching (C-O-
C), N-H bending (-NH2), and C=O stretching (NHCOCH3
 
Fig. 4: FTIR spectrum of MMW chitosan 
 
Pillarization Na-montmorillonit nanocomposite with MMW 
chitosan 
) amida I. 
  
Pillarization or intercalation is an inclusion of pillar agent into the 
interlayer of clay silicate so intercalated clay compound was 
obtained. Pillarization will increase chemical and physical properties 
including basal spacing (d001), specific surface area, porosity and 
acidity of MMT. This study used medium molecular weight chitosan 
to intercalate Na-MMT. Intercalation with polihydroxycation 
followed by heating will form intercalated clay with high thermal 
stability. The intercalated Na-MMT mineral was detected by analysis 
using XRD, FT-IR spectrophotometer and SEM. X-ray diffraction used 
for analyzing mineral in the qualitative and quantitative way. 
Qualitative analysis was conducted by matching the sample of 
diffractogram with JCPDS standard data of MMT. While the 
quantitative analysis was conducted by focusing diffractogram 
review at angle of 2θ under 60, because this area showed chitosan 
was in the space between the layers. If a new peak appeared under 
initial peak, the basal spacing (d001) was increased, marked by 2θ 
shift to the left or 2θ peak appeared which dominantly had a smaller 
value from the initial peak. 
Ainurofiq et al. 




Fig. 5: Diffractogram: a). Na-MMT b). Chitosan-Na MMT 
0.603:1.500 c). Chitosan-Na MMT 1.206:1.500 d). Chitosan-Na 
MMT 2.415:1.500 e). Chitosan-Na MMT 4.830:1.500 
In figure 5a) demonstrates Na-MMT diffractogram before 
intercalation process. MMT before intercalation characterized by the 
presence of peak at 5.8000 which was basal spacing from Na-MMT 
with d value of 15.225 Å. Figure 5b) to 5e) displayed the result from 
diffractogram of intercalated Na-MMT by chitosan with different 
ratio. For example in figure 5d) disappearance of 5.8000 peaks 
characterized by appearance of new peak which dominant at 
2θ=5.5410
Every mineral has a typical vibration absorbance pattern that allows 
to identify the mineral and also to find out the presence of main 
functional groups in the identified structure compound. Shifting of 
wave numbers toward a smaller one was the proof of chitosan 
entering MMT. Change of wave numbers from chitosan, Na-MMT and 
each composite were shown in figure 6. 
 indicated that basal spacing was increasing, this was 
reinforced by the increasing of d value to 15.937 Å, which was the 
highest d value compared to other ratio composition, so the material 
was conducted for dissolution evaluation. 
Figure 6 shows that the initial MMT sample had Si-O/Al-O groups, -
O-Al-O- groups, -O-Si-O- groups, O-H groups at H2O and O-H groups 
from Si-OH groups and Al-OH groups. The presence of functional 
groups showed that on the initial MMT clay sample had 
aluminosilicate structure and Si-O-Si ring. Spectra IR of intercalated 
Na-MMT by MMW chitosan showed that intercalation with chitosan 
did not damage the MMT aluminosilicate structure. Vibration 
frequency was at 1597.06 cm-1 on the first chitosan which was the 
vibration absorbance of NH3 (δNH3), protonated amino groups also 
appeared on intercalated chitosan composite of which frequency 
was decreased with the increasing of total chitosan needed. A 
chitosan intercalation on Na-MMT was already occurred at this 
wavelength because of hydrogen bond between amino with Na-
MMT. The larger the amino groups means the greater of possibility 
to form hydrogen bonds. This was the reason for wavelength 
decreased significantly. Another chitosan group absorbance like C-O 
sym stretching at wave length of 1033.85 cm-1 was not seen, because 
overlapping the vibration absorbance strain –O-Al-O and –O-Si-O- 
found in Na-MMT. Besides, amino groups absorbance at 3425.58 cm-
1
The analysis result of surface morphology from composite using 
SEM are given in figure 7. 
 found in chitosan also overlapping the absorbance of O-H group 




Fig. 6: FTIR spectra of MMT Intercalated chitosan: a). MMW chitosan; b). Na MMT; c). Chitosan-Na MMT 0.603:1.500; d). Chitosan-Na MMT 
1.206:1.500; e). Chitosan-Na MMT 2.415:1.500; f). Chitosan-Na MMT 4.830:1.500 
Ainurofiq et al. 




a    b 
Fig. 7: a). SEM photograph of MMT b). SEM photograph of chitosan-Na MMT with a magnification of 1000x. 
 
Characterization of surface morphology with SEM shown different 
surface structure between MMT and composite of chitosan-Na MMT. 
The analysis result shown that chitosan formation inside interlayer 
surface or MMT surface result in changes of morphology with silica 
layers stacked with one another (intercalated composite) and silica 
layer which were layered by MMT. This SEM analysis result matched 
the XRD analysis result that produced increase in basal spacing 
value which was relatively small. This small increase indicated that 
most of chitosan were on MMT surface. 
Evaluation properties of granules  
The aim of this evaluation was to find out whether the used granules 
met the requirements based on the reference. The results of 
granules physical properties were demonstrated in table 2. 
Good flow time for granules is less than 10 seconds for 100 grams of 
granules [29]. Angle of repose is a series examination of granules 
flow time, granules have a good fluidity at the angle of repose of 250-
450
Evaluation properties of tablet  
 and the smaller value of angle of repose shows a better 
characteristic [30]. A good granules have carr’s index value for less 
than 20% [31]. Based on the data from the table, everything met the 
requirements based on the reference. It indicated that the granules 
in this study were feasible and relatively fine. The results were 
analyzed statistically by using ANOVA with level confidence interval 
of 95% showed sig value > 0.05 for all evaluations of physical 
properties of granule, which means there was no significant 
difference between formula compositions against physical 
properties of granule. 
This evaluation aims to find out the quality of tablets produced, 
whether it meets the standard that has been set or not. The results 
of the tablets physical properties evaluation were demonstrated in 
table 3. 
 
Table 2: Granules physical properties 
Formula  FI FII FIII FIV 
Flow time (second)  10.749 ± 1.654 9.887 ± 0.532 7.048 ± 1.373 9.342 ± 2.631 
Angle of repose (0 29.750 ± 1.081 ) 28.026 ± 1.159 28.778 ± 2.400 28.831 ± 2.137 
Carr’s index (%) 12.031 ± 3.517 13.411 ± 6.221 11.469 ± 2.937 11.469 ± 2.856 
 
Table 3: Physical properties and release rate of tablets 
Test FI FII FIII FIV 
Weight variation (mg) 478.7 ± 2.003 (CV=0.325) 495.65 ± 2.834 (CV=0.386) 494.05 ± 3.41 (CV=0.424) 489.60 ± 3.648 
(CV=0.745) 
Hardness (N) 66.98 ± 0.495  66.29 ± 1.841 72.54 ± 0.673 66.78±2.100 
Friability (%) 2.620 ± 2.674  0.733 ± 0.348 0.875 ± 0.145 1.159 ± 0.359 
DE360 59.995  (%) 31.573 43.971 48.779 
 
The requirement of weight variation for non-coating tablets with 
average tablet weight more than 300 mg was weighted one by one, it 
cannot be more than 2 tablets stray more than 5% and not even one 
tablet stray more than 10% from the average weight [32]. The 
calculation results of tablets weight variation on four of the formulas 
showed that there were no tablet strayed for more than 5% and not 
even one tablet strayed more than 10% from the average weight. 
Friability stated in percent which referring to the initial tablet mass 
before evaluation. Good tablet has friability value not more than 0.5-
1% [31]. Friability data on FI and FIV did not meet the requirements. 
So FI (without matrix) was relatively more friable compared to other 
formulas. In this study, tablet hardness from four of the formulas was 
maintained between 60-70 N. The results of the statistical analysis 
with one way ANOVA showed that there was no significant difference 
between one formula and another, with significant value >0.05, so the 
physical properties of the tablets was the same. Statistical test results 
for four of the formulas were not significantly different, because 
formulation of tablet hardness was maintained the same, so that 
dissolution parameters were not affected by tablet hardness. 
 
Fig. 8: Dissolution profile of theophylline tablet 
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In Vitro Drug Release 
Dissolution test aims to find out profile of theophylline release from 
tablet In Vitro way. This test was conducted using dissolution 
apparatus XXIII USP model with phosphate buffer pH 7.2 medium 
maintained at body temperature 370± 0.5° for 6 hours. Before 
testing, maximum wavelength was measured for theophylline 
solution and standard curve measurement. Scanning results 
obtained maximum wavelength of 272 nm. Standard curve linear 
regression equation obtained from plot between theophylline levels 
and absorbance was y = 0.0615 x + 0.0159, R2
Dissolution results of theophylline sustained release tablet made in 
the curve, between theophylline levels released (%) and time 
presented in figure 8. 
 = 0.999. This equation 
could be used to set the levels of typical compounds from a sample 
in the same medium. 
Release of theophylline active substances could be seen in four of 
the dissolution profiles shown in figure 8. FI was a conventional 
preparation so active substances released quickly, FII that contains 
HPMC matrix released gradually and active substances released 
slowly, while FIII and FIV which contains MMT matrix and 
intercalated Na-MMT by MMW chitosan slowly released with its 
profile between without MMT formula (FI) and HPMC matrix 
properties. The ability of poloxamer 188 modified MMT clay to 
prolong the release of the drug as compared to that of the pristine 
drug without MMT [33]. HPMC has a high viscosity so the formed gel 
layer was relatively difficult to be further eroded by solvent. It 
caused matrix difficult to experience erosion, so theophylline 
diffusion to exit from matrix occurred slowly. FIII that contains MMT 
matrix gave a good drug release profile, slowly and between profile 
range of FI and FII. The matrix would swell and formed gel layers 
around the properties with specific viscosity on contact with solvent 
medium and the drug would be diffused through pores between 
matrixes. FII as a comparison was releasing drug dose slowly at the 
initial therapy, it was concerned that therapeutic effect was not soon 
achieved. FIII was faster on releasing drug at first, and then followed 
by constant slow release. While the FIV contained intercalated Na-
MMT by MMW chitosan with hydrophilic properties on contact with 
water, the matrix would swell then bind theophylline and made the 
drug release longer. 
It was supported by MMT characteristics which potentially become 
the carrier material of a sustained release properties. MMT had pores 
or basal spacing which able to insert theophylline inside, so MMT 
could release theophylline in sustained release and could be 
controlled. It was reported that MMT is a mineral group that’s able to 
be intercalated by other compound to form a new nanocomposite 
material, with method of cation exchange so d-spacing would became 
larger and more active substances could enter into matrix [34]. 
Based on Dissolution Efficiency (DE) value for every formula was 
shown in table 3 including FI 59.995; FII 31.573; FIII 43.971, and FIV 
48.779. DE Statistic test results using Kolmogorov-Smirnov showed 
that the obtained data normally distributed with p>0.05, then 
continued to one way ANOVA test that showed a significant 
difference between added matrix to tablet dissolution with 
signification value <0.05, test was continued to t-LSD test which 
obtained a significant difference between FI and FII, FIII and FIV. But 
there was no significant difference between FII and FIII nor FIV. So, 
statistically between FII, FIII and FIV there were no significant 
difference of matrix type variation. 
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CONCLUSION 
Characteristics of the MMT, Na-MMT, Na-MMT intercalated MMW 
chitosan did not change much. Sustained release tablet of 
theophylline with intercalated Na-montmorillonite matrix by MMW 
chitosan, was faster in drug release than with natural 
montmorillonite matrix, although statistically not significant and 
exhibited a prolonged release as compared to the pure drug without 
MMT. 
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